Literature DB >> 17658471

Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle.

Luca Mendler1, Zsuzsanna Baka, Andrea Kovács-Simon, László Dux.   

Abstract

Myostatin is an important negative regulator of skeletal muscle growth, while androgens are strong positive effectors. In order to investigate the possible interaction between myostatin and androgen pathways, we followed myostatin expression in the androgen-dependent levator ani (LA) muscle of the rat as a function of androgen status. By testosterone deprivation (castration), we induced LA growth arrest in young male rats, whilst atrophy in adult ones, however, both processes could be reversed by testosterone supplementation. After castration, a significant up-regulation of active myostatin protein (and its propeptide) was found, whereas the subsequent testosterone treatment reduced myostatin protein levels to normal values in both young and adult rats. Similarly, a testosterone-induced suppression of myostatin mRNA levels was observed in castrated adult but not in young animals. Altogether, androgens seem to have strong negative impact on myostatin expression, which might be a key factor in the weight regulation of LA muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658471     DOI: 10.1016/j.bbrc.2007.07.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Hormone treatment and muscle anabolism during aging: androgens.

Authors:  E Lichar Dillon; William J Durham; Randall J Urban; Melinda Sheffield-Moore
Journal:  Clin Nutr       Date:  2010-05-07       Impact factor: 7.324

Review 2.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

3.  Increased circulating myostatin in patients with type 2 diabetes mellitus.

Authors:  Fang Wang; Yonggan Liao; Xuefeng Li; Chunlin Ren; Changming Cheng; Yongsheng Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

4.  Myostatin, a profibrotic factor and the main inhibitor of striated muscle mass, is present in the penile and vascular smooth muscle.

Authors:  I Kovanecz; M Masouminia; R Gelfand; D Vernet; J Rajfer; N F Gonzalez-Cadavid
Journal:  Int J Impot Res       Date:  2017-05-25       Impact factor: 2.896

5.  Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice.

Authors:  H De Naeyer; S Lamon; A P Russell; I Everaert; A De Spaey; B Vanheel; Y Taes; W Derave
Journal:  Eur J Appl Physiol       Date:  2014-01-05       Impact factor: 3.078

6.  Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways.

Authors:  Ekaterina L Kovacheva; Amiya P Sinha Hikim; Ruoqing Shen; Indranil Sinha; Indrani Sinha-Hikim
Journal:  Endocrinology       Date:  2009-12-18       Impact factor: 4.736

7.  Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development.

Authors:  Ryan L Sheppard; Espen E Spangenburg; Eva R Chin; Stephen M Roth
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

8.  Mouse model of testosterone-induced muscle fiber hypertrophy: involvement of p38 mitogen-activated protein kinase-mediated Notch signaling.

Authors:  Danielle Brown; Amiya P Sinha Hikim; Ekaterina L Kovacheva; Indrani Sinha-Hikim
Journal:  J Endocrinol       Date:  2009-01-14       Impact factor: 4.286

Review 9.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

10.  TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.

Authors:  Chunliu Pan; Shalini Singh; Deepak M Sahasrabudhe; Joe V Chakkalakal; John J Krolewski; Kent L Nastiuk
Journal:  Endocrinology       Date:  2016-09-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.